Spain HIPRA is a world-leading animal health company that has launched a record 22 animal vaccines in the last 10 years. During the COVID-19 pandemic, the European company decided to jump into human health with its own vaccine candidate, currently in phase III trials. Carles Fàbrega, managing director of HIPRA’s new…
India Writing in the March 2022 edition of DIA’s Global Forum magazine, Ananya Chakraborty from the Vydehi Institute of Medical Sciences & Research Centre outlines the key factors behind India’s successful COVID-19 vaccination program. January 16, 2022, was a proud day for India. The country achieved the milestone of completing…
LatAm The latest from Latin American pharma, including Moderna’s push to build a regional presence and partnership network; Pfizer’s health equity challenges in the region; and Brazil’s local manufacturing of AstraZeneca’s vaccine and approval of three new cannabis-based products. Moderna partners with Latin American Pharma https://endpts.com/covid-19-roundup-scottish-government-invests-27m-in-valnevas-covid-19-manufacturing-moderna-partners-with-latin-american-pharma/ In a move to…
Global As the focus of the global COVID-19 pandemic response shifts downstream from the development and production of vaccines to vaccination campaigns themselves, IFPMA Director-General Thomas Cueni lays out the biopharmaceutical industry’s three new overarching priorities: supporting country readiness, contributing to equitable distribution, and driving innovation. From the early days…
China A selection of recent top stories from the Chinese pharma industry, including China’s conditional approval of Pfizer’s COVID treatment pill Paxlovid; a new push to combat monopoly practices and unfair competition in the domestic industry; and US FDA concerns about the applicability of Chinese clinical trial results for the US…
Spain As Spain’s Prime Minister, Pedro Sanchez, became the latest leader to call for COVID-19 to be treated as an endemic illness like the flu, regional health authorities warn that it might be too soon, going as far as calling it a “serious mistake,” an opinion echoed by the World Health…
Asia-Pacific Stewart Campbell, Vice President and General Manager, Asia Pacific, West Pharmaceutical Services, highlights how the drug containment and delivery system industry is evolving to meet the rapidly changing needs of Asian biopharma; West’s crucial role in the fight against COVID-19 and how it met surging demands for injectable packaging in…
Global Over two years since the first cases of COVID-19, the world is still coming to terms with the virus. While vaccines have been developed and rolled out in record time in high-income countries, the developing world risks falling behind. Less than ten percent of the African continent has been vaccinated,…
China PPC China’s Sophia Duan, writing in the January edition of DIA’s Global Forum magazine, details how the emergence of an effective pharmacovigilance ecosystem is helping to safeguard the rollout of COVID-19 vaccines in China. Since the breakout of COVID-19, many pharmaceutical companies in China have worked to develop preventative…
Saudi Arabia Jean Paul Scheuer, General Manager for Sanofi Genzyme and MCO Lead for Greater Gulf, highlights the company’s expanding footprint in the region, the organizational changes brought about by global CEO Paul Hudson, and how Sanofi has managed to launch 20 new products in the last year. Sanofi has been quick…
Saudi Arabia SaudiVax intends to be the premier developer, manufacturer, and supplier of vaccines and biologics in Saudi Arabia and the MENA region, including halal vaccines. Co-Founder and Managing Director Professor Mazen Hassanain comments on the company’s ambitions, the opportunity that halal vaccines represent, how its J&J partnership will create the first…
See our Cookie Privacy Policy Here